Huvudbild för Vitalis 2024
Profilbild för Early Accessible Person-centred Rehabilitation for Patients with Chronic Pain (EAPER-P) - A randomized controlled trial

Early Accessible Person-centred Rehabilitation for Patients with Chronic Pain (EAPER-P) - A randomized controlled trial Har passerat

Onsdag 15 maj 2024 14:30 - 15:13 Poster Arena

Rapportör: Åse Lundin

Spår: Posters, Evaluation of Interventions

Poster can be found in location 108.

Background: Chronic pain is a public health issue and a leading cause of years lived with disability worldwide. Chronic pain is defined as pain that persists or recurs for more than three months and is today recognized as a disease in its own right. Both the societal costs and personal consequences of chronic pain is substantial. People on sick leave due to chronic pain often have difficulties returning to work. The effects of person-centred care interventions on a person’s self-efficacy as well as level of sick leave has been investigated in previous research on different populations and diagnoses. However, little is known regarding the effects of person-centred care interventions for persons being on sick leave from work due to chronic pain. Objective: To evaluate if an early person-centred rehabilitation intervention, consisting of a combined e-health platform and telephone support, increases self-efficacy and return to work in persons on sick leave due to chronic pain. Methods: A randomized controlled trial with two arms. The control group receives usual care, whereas the intervention group receives usual care with the addition of a person-centred intervention comprising access to an e-health platform and person-centred telephone calls with a health care professional during a 6-month period. The primary outcome is a composite score of changes in general self-efficacy (GSE) and level of sick leave at the 6-month follow-up. Status: 60 participants on sick leave due to chronic pain has been recruited from 11 primary health care centers across Gothenburg, Sweden. Participants were allocated to either a control group (n=30) or an intervention group (n=30). Screening was stopped in June 2023; the intervention will continue for the succeeding 6 months. Statistical analyses will be carried out on the collected data during fall 2023. Preliminary results are expected in early spring 2024.  

Språk

English

Seminarietyp

Poster

Konferens

GCPCC

Authors

Åse Lundin, Veronica Lilja, Inger Ekman, Paulin Andréll, Mari Lundberg, Sara Wallström

Föreläsare

Profilbild för Åse Lundin

Åse Lundin Rapportör